Dr. Sharad Soni, M.D

NPI: 1295701357
Total Payments
$610.13
2021 Payments
$15.12
Companies
10
Transactions
20
Medicare Patients
2,324
Medicare Billing
$360,756

Payment Breakdown by Category

Food & Beverage$610.13 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $610.13 20 100.0%

Top Paying Companies

Company Total Records Latest Year
Horizon Pharma plc $175.09 8 $0 (2018)
Janssen Pharmaceuticals, Inc $154.07 2 $0 (2019)
AstraZeneca Pharmaceuticals LP $84.28 1 $0 (2017)
Actelion Pharmaceuticals US, Inc. $71.69 1 $0 (2017)
Merck Sharp & Dohme Corporation $39.82 3 $0 (2020)
Avanir Pharmaceuticals, Inc. $24.56 1 $0 (2017)
ACADIA Pharmaceuticals Inc $19.40 1 $0 (2017)
GlaxoSmithKline, LLC. $15.12 1 $0 (2021)
Novartis Pharmaceuticals Corporation $13.60 1 $0 (2020)
SANOFI-AVENTIS U.S. LLC $12.50 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2021 $15.12 1 GlaxoSmithKline, LLC. ($15.12)
2020 $42.39 3 Merck Sharp & Dohme Corporation ($28.79)
2019 $132.44 2 Janssen Pharmaceuticals, Inc ($121.41)
2018 $155.13 7 Horizon Pharma plc ($155.13)
2017 $265.05 7 AstraZeneca Pharmaceuticals LP ($84.28)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/10/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.12 General
Category: RESPIRATORY
06/15/2020 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO Food and Beverage In-kind items and services $17.05 General
Category: ENDOCRINOLOGY
02/25/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.60 General
Category: CARDIOVASCULAR
02/18/2020 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO Food and Beverage In-kind items and services $11.74 General
Category: ENDOCRINOLOGY
12/10/2019 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLUJAN Food and Beverage In-kind items and services $11.03 General
Category: ENDOCRINOLOGY
02/26/2019 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $121.41 General
Category: Cardiovascular & Metabolism
11/20/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $4.56 General
Category: RAYOS
10/30/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $3.84 General
Category: RAYOS
10/09/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $4.22 General
Category: RAYOS
09/04/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $4.80 General
Category: RAYOS
07/17/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $4.63 General
Category: RAYOS
04/19/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage Cash or cash equivalent $128.18 General
Category: RAYOS
04/10/2018 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $4.90 General
Category: RAYOS
12/12/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $32.66 General
Category: Cardiovascular & Metabolism
11/08/2017 Actelion Pharmaceuticals US, Inc. Food and Beverage In-kind items and services $71.69 General
06/28/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $84.28 General
Category: Cardiovascular and Metabolism
06/15/2017 Avanir Pharmaceuticals, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $24.56 General
Category: pseudobulbar affect (PBA)
03/09/2017 SANOFI-AVENTIS U.S. LLC SOLIQUA (Drug) Food and Beverage In-kind items and services $12.50 General
Category: DIABETES
02/13/2017 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $19.40 General
Category: PDP
01/25/2017 Horizon Pharma plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $19.96 General
Category: RAYOS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 335 792 $129,300 $54,320
2022 26 629 1,474 $256,820 $107,153
2021 27 622 1,346 $232,475 $100,573
2020 24 738 1,449 $244,400 $98,710
Total Patients
2,324
Total Services
5,061
Medicare Billing
$360,756
Procedure Codes
101

All Medicare Procedures & Services

101 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99491 Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month Office 2023 22 106 $10,600 $7,574 71.5%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 24 112 $16,800 $7,502 44.7%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Office 2023 17 79 $11,850 $5,527 46.6%
99348 Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes Office 2023 18 74 $15,225 $4,888 32.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 25 56 $8,400 $3,981 47.4%
99347 Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes Office 2023 24 101 $17,725 $3,715 21.0%
99349 Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes Office 2023 20 31 $7,750 $3,317 42.8%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 31 36 $9,900 $3,280 33.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 16 16 $3,625 $2,428 67.0%
99350 Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes Office 2023 13 14 $4,200 $2,092 49.8%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Office 2023 15 21 $5,775 $2,084 36.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 13 18 $4,500 $1,804 40.1%
99316 Nursing facility discharge management, more than 30 minutes Facility 2023 13 13 $2,050 $1,566 76.4%
90662 Influenza vaccine split virus, preservative free Office 2023 19 19 $2,850 $1,367 48.0%
99307 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes Office 2023 13 31 $3,100 $1,140 36.8%
99307 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes Facility 2023 21 34 $3,400 $1,113 32.7%
G0008 Administration of influenza virus vaccine Office 2023 19 19 $950.00 $678.87 71.5%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 12 12 $600.00 $264.24 44.0%
99491 Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month Office 2022 38 238 $24,800 $17,975 72.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 29 193 $30,100 $13,037 43.3%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 35 172 $25,800 $10,318 40.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 41 95 $14,250 $6,958 48.8%
99334 Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes Office 2022 18 106 $31,800 $5,469 17.2%
99335 Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes Office 2022 21 63 $20,475 $4,842 23.6%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 44 55 $15,125 $4,704 31.1%

About Dr. Sharad Soni, M.D

Dr. Sharad Soni, M.D is a Internal Medicine healthcare provider based in Ozone Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295701357.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharad Soni, M.D has received a total of $610.13 in payments from pharmaceutical and medical device companies, with $15.12 received in 2021. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($610.13).

As a Medicare-enrolled provider, Soni has provided services to 2,324 Medicare beneficiaries, totaling 5,061 services with total Medicare billing of $360,756. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Ozone Park, NY
  • Active Since 02/27/2006
  • Last Updated 07/22/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1295701357

Products in Payments

  • RAYOS (Drug) $175.09
  • INVOKANA (Drug) $154.07
  • FARXIGA (Drug) $84.28
  • JANUVIA (Drug) $39.82
  • NUEDEXTA (Drug) $24.56
  • NUPLAZID (Drug) $19.40
  • TRELEGY ELLIPTA (Drug) $15.12
  • ENTRESTO (Drug) $13.60
  • SOLIQUA (Drug) $12.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Ozone Park